Focused on Cancer—Focused on You
In the fight of your life, choosing a provider who shares your focus can make all the difference.
Have a question? Call the clinic location closest to you, or our main number, 1-888-259-7622.
Comprehensive Care, Proven Outcomes
Since 1992, Rocky Mountain Cancer Centers (RMCC) has been a leader in cancer care. We began as a small group practice of six physicians with a new approach to treating cancer—administering chemotherapy on an outpatient basis—and have since developed into Colorado's largest and most comprehensive provider of cancer care with more than 50 physicians treating patients in 20 community-based locations across the state.
Through our culture of respect and collaboration we practice evidence-based medicine and participate in clinical research to create value and positive outcomes for our patients and families, referring physicians and payers.
Expertise in Rare and Common Cancers
No matter what cancer type you've been diagnosed with our team of nationally recognized doctors and support providers are here to help with personalized treatment plans that include the most advanced treatment options and therapies.
Experience When It Matters Most
Our statewide physician network includes nationally recognized experts in cancer care and research—experience you want and deserve when it matters most.View All Providers
Cancer Care Close To Home
With 20 outpatient cancer treatment centers across Colorado, we provide convenient, cost-effective, comprehensive cancer care close to home. Our state-of-the-art facilities have everything you need to fight cancer.
A Phase II Study of Pembrolizumab (MK-3475) as Monotherapy in Subjects with Previously Treated Locally Advanced Unresectable or Metastatic (Stage IV) Mismatched Repair Deficient or Microsatellite Instability-High Colorectal Carcinoma (KEYNOTE-164), NCT02460198
PURPOSE OF THIS CLINICAL RESEARCH TRIAL: In this study, participants with previously-treated locally-advanced unresectable or metastatic mismatched repair (MMR) deficient or microsatellite instability (MSI) high colorectal carcinoma (CRC) will be treated with pembrolizumab (MK-3475, KEYTRUDA®) monotherapy. There will be two cohorts in this study: Cohort A and Cohort B. For Cohort A, participants are required […]Read More
Treatment and Services
As a Rocky Mountain Cancer Centers patient your cancer care will be overseen by a medical oncologist/hematologist. As your primary cancer care physician he/she will manage your treatment plans and medical therapies—including the administering of chemotherapy; monitor and evaluate your progress; and collaborate with other medical caregivers on additional treatment options like radiation therapy. He/she will lead a team of highly trained clinical providers including physician assistants, nurse practitioners and oncology-trained nurses, fighting cancer on your behalf.Read More
Patients and Experts Gather in Denver for Neuroendocrine Tumor Conference
Doctors are taught, “if you hear hooves, think horses,” says Rocky Mountain Cancer Centers surgeon Dr. Eric Liu, MD. But once in a while, those hooves belong to a zebra. And, every so often, that sudden flushing, or those recurring stomach aches aren’t the common, expected ailments. Sometimes they are indications of the rare and rarely understood neuroendocrine cancer. Read More